Cost-effectiveness of smoking cessation to prevent age-related macular degeneration
<p>Abstract</p> <p>Background</p> <p>Tobacco smoking is a risk factor for age-related macular degeneration, but studies of ex-smokers suggest quitting can reduce the risk.</p> <p>Methods</p> <p>We fitted a function predicting the decline in risk...
Main Authors: | Matthews Jane P, Hurley Susan F, Guymer Robyn H |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-09-01
|
Series: | Cost Effectiveness and Resource Allocation |
Online Access: | http://www.resource-allocation.com/content/6/1/18 |
Similar Items
-
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
by: Matthews Jane P, et al.
Published: (2008-06-01) -
Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
by: Eleonora M. Lad, et al.
Published: (2023-09-01) -
Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration
by: Amy C. Cohn, et al.
Published: (2021-01-01) -
Role of sleep-disordered breathing in age-related macular degeneration
by: Zhichao Wu, et al.
Published: (2023-10-01) -
New Technologies to Study Functional Genomics of Age-Related Macular Degeneration
by: Tu Nguyen, et al.
Published: (2021-01-01)